These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7972236

  • 1. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.
    Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
    [Abstract] [Full Text] [Related]

  • 2. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.
    Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.
    Nat Genet; 1993 Jun; 4(2):191-4. PubMed ID: 8102299
    [Abstract] [Full Text] [Related]

  • 3. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T, Sjöberg RM, Hedborg F, Kogner P.
    Cancer Res; 1995 Dec 01; 55(23):5681-6. PubMed ID: 7585654
    [Abstract] [Full Text] [Related]

  • 4. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R.
    Nat Genet; 1993 Jun 01; 4(2):187-90. PubMed ID: 8102298
    [Abstract] [Full Text] [Related]

  • 5. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD, Maris JM, White PS, Guo C, Brodeur GM.
    Med Pediatr Oncol; 2001 Jan 01; 36(1):52-5. PubMed ID: 11464906
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM.
    Cancer Res; 1992 Apr 01; 52(7):1780-5. PubMed ID: 1551108
    [Abstract] [Full Text] [Related]

  • 7. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
    Grandinetti KB, Spengler BA, Biedler JL, Ross RA.
    Oncogene; 2006 Feb 02; 25(5):706-12. PubMed ID: 16278682
    [Abstract] [Full Text] [Related]

  • 8. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.
    N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999
    [Abstract] [Full Text] [Related]

  • 9. Allelotype of neuroblastoma.
    Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J.
    Oncogene; 1995 Nov 02; 11(9):1829-34. PubMed ID: 7478611
    [Abstract] [Full Text] [Related]

  • 10. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.
    Christiansen H, Delattre O, Fuchs S, Theobald M, Christiansen NM, Berthold F, Lampert F.
    Prog Clin Biol Res; 1994 Nov 02; 385():19-25. PubMed ID: 7972212
    [Abstract] [Full Text] [Related]

  • 11. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R.
    Oncogene; 1995 Jan 19; 10(2):291-7. PubMed ID: 7838528
    [Abstract] [Full Text] [Related]

  • 12. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
    Bièche I, Champème MH, Lidereau R.
    Cancer Res; 1994 Aug 15; 54(16):4274-6. PubMed ID: 7913873
    [Abstract] [Full Text] [Related]

  • 13. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
    Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R.
    Genes Chromosomes Cancer; 2001 Jun 15; 31(2):172-81. PubMed ID: 11319804
    [Abstract] [Full Text] [Related]

  • 14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H.
    Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780
    [Abstract] [Full Text] [Related]

  • 15. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Ohtsu K, Hiyama E, Ichikawa T, Matsuura Y, Yokoyama T.
    Clin Cancer Res; 1997 Jul 15; 3(7):1221-8. PubMed ID: 9815803
    [Abstract] [Full Text] [Related]

  • 16. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.
    N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019
    [Abstract] [Full Text] [Related]

  • 17. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T.
    Med Pediatr Oncol; 2001 Jan 24; 36(1):67-74. PubMed ID: 11464909
    [Abstract] [Full Text] [Related]

  • 18. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.
    Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugières L, Voûte PA, Westerveld A.
    Hum Mol Genet; 1995 Apr 24; 4(4):535-9. PubMed ID: 7633401
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M.
    Oncogene; 1992 Jun 24; 7(6):1185-9. PubMed ID: 1594247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.